top
Search terms
Results 31 - 40 of 160 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 16
Ehjournal

Citation Marco Valgimigli, Francesco Costa, Yuliya Lokhnygina, Robert M. Clare, Lars Wallentin, David J. Moliterno, Paul W. Armstrong, Harvey D. White, Claes Held, Philip E. Aylward, Frans Van de ...

European Heart Journal, Valgimigli, Marco, Costa, Francesco, Lokhnygina, Yuliya, Clare, Robert M., Wallentin, Lars, Moliterno, David J., Armstrong, Paul W., White, Harvey D., Held, Claes, Aylward, ...

Date : 09/03/2017 Item size : 160370 bytes
Ehjournal

Introduction Since publication of the landmark trials 4S, CARE and LIPID, HMG-coA reductase inhibitors (statins) are recognized as effective treatment for secondary prevention of cardio-vascular ...

European Heart Journal, Lenderink, Timo, Boersma, Eric, Gitt, Anselm K., Zeymer, Uwe, Wallentin, Lars, Van de Werf, Frans, Hasdai, David, Behar, Shlomo, Simoons, Maarten L.

Date : 01/08/2006
Ehjournal

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study Growth differentiation factor-15 ...

European Heart Journal, Hagström, Emil, James, Stefan K., Bertilsson, Maria, Becker, Richard C., Himmelmann, Anders, Husted, Steen, Katus, Hugo A., Steg, Philippe Gabriel, Storey, Robert F., ...

Date : 21/04/2016 Item size : 270625 bytes
Ehjournal

3 ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  .  ACC/AHA 2006 guidelines for ...

European Heart Journal, Husted, Steen, Wallentin, Lars, De Caterina, Raffaele

Date : 01/10/2007 Item size : 99679 bytes
Ehjournal

1 ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  .  ACC/AHA 2007 guidelines for the ...

European Heart Journal, Eggers, Kai M., Wallentin, Lars, Wollert, Kai C.

Date : 01/12/2008 Item size : 101822 bytes
Ehjournal

Introduction Randomized clinical trials of cardiovascular diseases are increasingly recruiting patients globally in order to achieve the size necessary to provide reliable, conclusive overall ...

European Heart Journal, Pocock, Stuart, Calvo, Gonzalo, Marrugat, Jaume, Prasad, Krishna, Tavazzi, Luigi, Wallentin, Lars, Zannad, Faiez, Alonso Garcia, Angeles

Date : 21/06/2013
Ehjournal

Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke, major bleed, ...

European Heart Journal, Held, Claes, Hylek, Elaine M., Alexander, John H., Hanna, Michael, Lopes, Renato D., Wojdyla, Daniel M., Thomas, Laine, Al-Khalidi, Hussein, Alings, Marco, Xavier, Dennis, ...

Date : 21/05/2015
Ehjournal

In NSTE-ACS patients, the primary endpoint was reduced with ticagrelor vs. clopidogrel [10.0 vs. 12.3%; hazard ratio (HR) 0.83; 95% confidence interval (CI) = 0.740.93], as was myocardial infarction ...

European Heart Journal, Lindholm, Daniel, Varenhorst, Christoph, Cannon, Christopher P, Harrington, Robert A, Himmelmann, Anders, Maya, Juan, Husted, Steen, Steg, Philippe Gabriel, Cornel, Jan H, ...

Date : 14/08/2014
Ehjournal

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial Abstract Aims The ...

European Heart Journal, Husted, Steen, James, Stefan K., Bach, Richard G., Becker, Richard C., Budaj, Andrzej, Heras, Magda, Himmelmann, Anders, Horrow, Jay, Katus, Hugo A., Lassila, Riita, Morais, ...

Date : 14/06/2014 Item size : 305378 bytes
Ehjcardiovascrec

Aspirin is good but not good enough The main arguments for this statement are the following: in patients with unstable coronary artery disease there is: 1. development of instability despite ongoing ...

Cardiovascular Research, Wallentin, Lars

Date : 01/02/1997 Item size : 111763 bytes